UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Raised by Donaldson Capital Management LLC

Donaldson Capital Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,821 shares of the healthcare conglomerate's stock after acquiring an additional 1,936 shares during the quarter. UnitedHealth Group comprises 2.1% of Donaldson Capital Management LLC's investment portfolio, making the stock its 18th biggest holding. Donaldson Capital Management LLC's holdings in UnitedHealth Group were worth $55,048,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the 3rd quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.3 %

NYSE UNH traded up $6.32 on Tuesday, hitting $486.54. 4,100,487 shares of the stock traded hands, compared to its average volume of 4,993,668. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average of $512.82 and a 200 day moving average of $552.00. The company has a market capitalization of $445.04 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.83 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. KeyCorp reaffirmed an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.